Kohli Prashant's most recent trade in Grace Therapeutics Inc. was a trade of 100,000 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on Sept. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Grace Therapeutics Inc | Prashant Kohli | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 09 Sep 2026 | 100,000 | 121,357 (0%) | 0% | 2.1 | 214,000 | Common Stock |
| Grace Therapeutics Inc | Prashant Kohli | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2026 | 267,160 | 267,160 | - | - | Stock Option (Right to Buy) | |
| Grace Therapeutics Inc | Prashant Kohli | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 225,400 | 225,400 | - | - | Stock Option (Right to Buy) | |
| Grace Therapeutics Inc | Prashant Kohli | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 128,770 | 128,770 | - | - | Stock Options (Right to Buy) | |
| Grace Therapeutics Inc | Kohli Prashant | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 41,668 | 41,668 | - | - | Stock Options (Right to Buy) | |
| Grace Therapeutics Inc | Prashant Kohli | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 208,334 | 208,334 | - | - | Stock Options (Right to Buy) |